Your browser doesn't support javascript.
loading
The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
Krutova, Marcela; Capek, Vaclav; Nycova, Elka; Vojackova, Sabina; Balejova, Magda; Geigerova, Lenka; Tejkalova, Renata; Havlinova, Lenka; Vagnerova, Iva; Cermak, Pavel; Ryskova, Lenka; Jezek, Petr; Zamazalova, Dana; Vesela, Denisa; Kucharova, Alice; Nemcova, Dana; Curdova, Martina; Nyc, Otakar; Drevinek, Pavel.
Afiliación
  • Krutova M; Department of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. marcela.krutova@lfmotol.cuni.cz.
  • Capek V; Bioinformatics centre, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Nycova E; Department of Medical Microbiology, Hospital Bulovka, Prague, Czech Republic.
  • Vojackova S; Department of Medical Microbiology, University Hospital Brno, Brno, Czech Republic.
  • Balejova M; Department of Medical Microbiology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic.
  • Geigerova L; Department of Medical Microbiology, Faculty of Medicine, Charles University and University Hospital Plzen, Plzen, Czech Republic.
  • Tejkalova R; Department of Medical Microbiology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic.
  • Havlinova L; Department of Medical Microbiology and Immunology, Hospital Liberec, Liberec, Czech Republic.
  • Vagnerova I; Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Hospital, Olomouc, Czech Republic.
  • Cermak P; Department of Medical Microbiology, Thomayer's Hospital, Prague, Czech Republic.
  • Ryskova L; Department of Clinical Microbiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Jezek P; Department of Clinical Microbiology and Parasitology, Hospital Pribram, Pribram, Czech Republic.
  • Zamazalova D; Department of Clinical Microbiology, Hospital Nove Mesto na Morave, Nove Mesto na Morave, Czech Republic.
  • Vesela D; Department of Medical Microbiology, Hospital Jindrichuv Hradec, Jindrichuv Hradec, Czech Republic.
  • Kucharova A; Department of Medical Microbiology, Hospital Tabor, Tabor, Czech Republic.
  • Nemcova D; Department of Clinical Microbiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Curdova M; Department of Clinical Microbiology, Military University Hospital, Prague, Czech Republic.
  • Nyc O; Department of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
  • Drevinek P; Department of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
Antimicrob Resist Infect Control ; 9(1): 98, 2020 06 30.
Article en En | MEDLINE | ID: mdl-32605598

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Clostridioides difficile / Infecciones por Clostridium / Moxifloxacino / Antibacterianos Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Antimicrob Resist Infect Control Año: 2020 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Clostridioides difficile / Infecciones por Clostridium / Moxifloxacino / Antibacterianos Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Antimicrob Resist Infect Control Año: 2020 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Reino Unido